What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Antibody
Moriya Tsuji focuses on Natural killer T cell, CD1D, Immunology, Antigen and Immune system.
Moriya Tsuji has included themes like Glycolipid, Interleukin 12, Cytokine and Cancer research in his Natural killer T cell study.
He combines subjects such as Cell biology and CD1 with his study of CD1D.
In CD1, Moriya Tsuji works on issues like Innate immune system, which are connected to Bacterial antigen.
As a member of one scientific family, Moriya Tsuji mostly works in the field of Antigen, focusing on Microbiology and, on occasion, T-cell receptor and Borrelia burgdorferi.
His Immune system study deals with Natural killer cell intersecting with Plasmodium berghei.
His most cited work include:
- Recognition of bacterial glycosphingolipids by natural killer T cells (811 citations)
- Recognition of bacterial glycosphingolipids by natural killer T cells (811 citations)
- Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. (541 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, Virology, Natural killer T cell, Immune system and Antigen.
The concepts of his Virology study are interwoven with issues in Epitope, Plasmodium falciparum, Malaria, Circumsporozoite protein and Immunogenicity.
Moriya Tsuji is involved in the study of Natural killer T cell that focuses on CD1D in particular.
His research integrates issues of CD1, Antigen presentation and Cell biology in his study of CD1D.
Moriya Tsuji focuses mostly in the field of Immune system, narrowing it down to matters related to Cytotoxic T cell and, in some cases, Major histocompatibility complex.
His Antigen study frequently draws connections to other fields, such as Microbiology.
He most often published in these fields:
- Immunology (51.52%)
- Virology (39.39%)
- Natural killer T cell (36.97%)
What were the highlights of his more recent work (between 2013-2021)?
- Immunology (51.52%)
- Virology (39.39%)
- Immune system (33.94%)
In recent papers he was focusing on the following fields of study:
Moriya Tsuji mainly investigates Immunology, Virology, Immune system, CD8 and Antigen.
His work deals with themes such as Plasmodium falciparum, Malaria, Immunization and Immunogenicity, which intersect with Virology.
He mostly deals with T cell in his studies of Immune system.
His studies in CD8 integrate themes in fields like Cytotoxic T cell, Cancer research, Melanoma and Dendritic cell.
Antigen is closely attributed to Microbiology in his work.
His Natural killer T cell study frequently draws connections between related disciplines such as Cell biology.
Between 2013 and 2021, his most popular works were:
- Model for In Vivo Assessment of Humoral Protection against Malaria Sporozoite Challenge by Passive Transfer of Monoclonal Antibodies and Immune Serum (61 citations)
- Long-Term Persistence of Donor Alveolar Macrophages in Human Lung Transplant Recipients That Influences Donor-Specific Immune Responses. (58 citations)
- Inhibiting the Plasmodium eIF2α Kinase PK4 Prevents Artemisinin-Induced Latency (47 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Antibody
The scientist’s investigation covers issues in Virology, Immunology, Immune system, Natural killer T cell and T cell.
His Virology research focuses on subjects like Plasmodium falciparum, which are linked to Immunity.
His Immunology study combines topics from a wide range of disciplines, such as Receptor, Alpha chain and Antimicrobial.
The concepts of his Immune system study are interwoven with issues in Cytotoxic T cell and Transplantation.
Particularly relevant to CD1D is his body of work in Natural killer T cell.
Moriya Tsuji interconnects Glycolipid, Microbiology and T-cell receptor in the investigation of issues within Antigen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
